Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Vaccines

Free Subscription 09.06.2025 1 BMJ 1 Clin Infect Dis 1 Indian Pediatr 1 J Immunol 1 J Infect 4 J Infect Dis 3 JAMA 1 Nat Immunol 1 Nat Med 1 Pediatr Infect Dis J 2 Pediatrics 1 PLoS Comput Biol 4 PLoS One 23 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. LOOI MK
   Trump watch: Confusion over covid-19 vaccination, HIV vaccine funding withdrawn, and more.
   BMJ. 2025;389:r1145.
   PubMed        
   
   

   
   Clin Infect Dis

2. XHAFERI A, Bino S, Daja R, Vasili A, et al
   Sociodemographic and Occupational Factors Associated With Coronavirus Disease 2019 Vaccine and Influenza Vaccine Uptake Among Healthcare Workers, in Albania, 2022-2023: A Multicenter Study.
   Clin Infect Dis. 2025 Jun 3:ciaf202. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Indian Pediatr

3. AGARWAL A, Sajlan S, Chawla R, Mathur SB, et al
   Seroprevalence of Hepatitis A in Non-vaccinated Adolescents Aged 9 to 12 Years in New Delhi, India: A Cross-Sectional Study.
   Indian Pediatr. 2025 Jun 3. doi: 10.1007/s13312-025-00090.
   PubMed         Abstract available
   
   

   
   J Immunol

4. ANTERASIAN C, Gela A, Mwambene TD, Shah JA, et al
   BCG induced innate immune response heterogeneity and susceptibility to pediatric tuberculosis.
   J Immunol. 2025 Apr 2:vkae062. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Infect

5. OLIVEIRA LVN, Hargarten JC, Wang R, Carlson D, et al
   Peripheral blood CD4(+) and CD8(+) T cell responses to Cryptococcus candidate vaccine antigens in human subjects with and without cryptococcosis.
   J Infect. 2025;91:106521.
   PubMed         Abstract available
   
   

   
   J Infect Dis

6. KNOX JJ, Lee I, Blumberg EA, Rosenfeld AM, et al
   B-Cell Subset Representation Predicts SARS-CoV-2 Vaccine Response in Solid Organ Transplant Recipients.
   J Infect Dis. 2025 Jun 3:jiaf250. doi: 10.1093.
   PubMed         Abstract available
   
   
7. NAYAGAM SN, Coote W, Carroll MT, Toh ZQ, et al
   Differentiating SARS-CoV-2 antibody responses between infection and vaccination: challenges for epidemiological research.
   J Infect Dis. 2025 Jun 3:jiaf295. doi: 10.1093.
   PubMed        
   
   
8. ZHAI PY, Zang X, Jiang T, Feng J, et al
   Health and Economic Impacts of Introducing Vaccae and Enhanced Drug-Resistant Tuberculosis Management Strategies in China.
   J Infect Dis. 2024 Nov 22:jiae590. doi: 10.1093.
   PubMed         Abstract available
   
   
9. HUANG X, Wu J, Xu J, Wang H, et al
   Mycobacterium tuberculosis Antigen Rv1471 Induces Innate Immune Memory and Adaptive Immunity against Infection.
   J Infect Dis. 2024 Nov 14:jiae572. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   JAMA

10. ANDERER S
    RSV Vaccine Shows Real-World Effectiveness in Older Adults.
    JAMA. 2025 May 30. doi: 10.1001/jama.2025.7762.
    PubMed        
    
    
11. DONG E, Saiyed S, Nearchou A, Okura Y, et al
    Trends in County-Level MMR Vaccination Coverage in Children in the United States.
    JAMA. 2025 Jun 2:e258952. doi: 10.1001/jama.2025.8952.
    PubMed        
    
    
12. PRASAD V, Kaslow DC, Yang S
    Pausing Chikungunya Vaccination and Accelerated Approval.
    JAMA. 2025 Jun 5. doi: 10.1001/jama.2025.9393.
    PubMed        
    
    

    
    Nat Immunol

13. QUIRK GE, Schoenle MV, Peyton KL, Uhrlaub JL, et al
    Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections.
    Nat Immunol. 2025;26:829-836.
    PubMed         Abstract available
    
    

    
    Nat Med

14. NDEMBI N, Mutesa L, Muvunyi CM, Kim JH, et al
    Bridging the vaccine divide.
    Nat Med. 2025 Jun 2. doi: 10.1038/s41591-025-03728.
    PubMed        
    
    

    
    Pediatr Infect Dis J

15. CALLAGHAN T, Wise LA, Regan AK
    Intention to Use RSVpreF Vaccine or Nirsevimab to Prevent Infant RSV Among Pregnant Individuals.
    Pediatr Infect Dis J. 2025 Jun 3. doi: 10.1097/INF.0000000000004889.
    PubMed         Abstract available
    
    

    
    Pediatrics

16. TIETBOHL CK, Gurfinkel D, Duran D, Saville A, et al
    Feasibility and Acceptability of Recommending HPV Vaccine at Ages 9-10 Years.
    Pediatrics. 2025 Jun 2:e2024069625. doi: 10.1542/peds.2024-069625.
    PubMed         Abstract available
    
    
17. NAURECKAS LI C, Kaplan SL, Edwards KM, Marshall GS, et al
    What's Old Is New Again: Measles.
    Pediatrics. 2025;155:e2025071332.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

18. CHEN S, Venkatesan S, Arnetorp S, Bergenheim K, et al
    Features influencing the health and economic impact of preventing COVID-19 in immunocompromised individuals.
    PLoS Comput Biol. 2025;21:e1013072.
    PubMed         Abstract available
    
    

    
    PLoS One

19. FATIREGUN AA, Nic Lochlainn L, Kabore L, Dosumu M, et al
    Correction: Missed opportunities for vaccination among children aged 0-23 months visiting health facilities in a southwest State of Nigeria, December 2019.
    PLoS One. 2025;20:e0325918.
    PubMed         Abstract available
    
    
20. CARAZO S, Skowronski DM, Brousseau N, Guay CA, et al
    Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: Impact of variant replacement and waning protection during 10-month follow-up.
    PLoS One. 2025;20:e0325269.
    PubMed         Abstract available
    
    
21. HARTVIGSEN G, Dimitroff Y
    Modeling the SARS-CoV-2 epidemic and the efficacy of different vaccines across different network structures.
    PLoS One. 2025;20:e0325129.
    PubMed         Abstract available
    
    
22. PODDA M, Savojardo C, Luigi Martelli P, Casadio R, et al
    A descriptor-free machine learning framework to improve antigen discovery for bacterial pathogens.
    PLoS One. 2025;20:e0323895.
    PubMed         Abstract available
    
    

    
    Vaccine

23. CHAIWONG W, Takheaw N, Laopajon W, Nisoong C, et al
    Low-dose intradermal mRNA-1273 boosting vaccine following BBiBP-CorV vaccination during the omicron pandemics.
    Vaccine. 2025;61:127330.
    PubMed         Abstract available
    
    
24. ROUX K, Roux F, Burns S, Guy R, et al
    Effective strategies in human papillomavirus (HPV) vaccination interventions to increase uptake in rural, low socioeconomic, indigenous and migrant populations: A scoping review.
    Vaccine. 2025;61:127359.
    PubMed         Abstract available
    
    
25. MOHAMMADI S, Sisay MM, Saraswati PW, Osman AK, et al
    COVID-19 vaccine safety studies among special populations: A systematic review and meta-analysis of 120 observational studies and randomized clinical trials.
    Vaccine. 2025;61:127342.
    PubMed         Abstract available
    
    
26. COSTELLO LM, Kerns EK, McCulloh RJ, Roberts JR, et al
    Hesitancy and confidence in pediatric COVID-19 vaccination among diverse caregivers of unvaccinated children.
    Vaccine. 2025;61:127245.
    PubMed         Abstract available
    
    
27. KIM C, Lee D, Oh YW, Jung SJ, et al
    Association between parental and child influenza vaccination: A national health survey analysis.
    Vaccine. 2025;61:127345.
    PubMed         Abstract available
    
    
28. KOBAYASHI K, Masuda K, Wu JT, Lin L, et al
    Impact of digital communication message on HPV vaccine decision-making among Japanese mothers: A randomized controlled trial.
    Vaccine. 2025;61:127327.
    PubMed         Abstract available
    
    
29. YI Z, Owusu-Edusei K, Elbasha EH
    Economic evaluation of PCV21 in PCV-naive adults aged 50-64 years in the United States.
    Vaccine. 2025;59:127264.
    PubMed         Abstract available
    
    
30. LI H, Zhang J, Guo R, Li J, et al
    Immunogenicity evaluation of a recombinant pseudorabies virus co-expressing PCV2 and PCV3 capsid proteins in mice and piglets.
    Vaccine. 2025;60:127307.
    PubMed         Abstract available
    
    
31. PIAL RH, Capeding MR, Song KR, Park EL, et al
    Immune persistence after 5 years of vaccination by Vi-DT vaccine among children below 2 years: Result from long-term observational study.
    Vaccine. 2025;60:127304.
    PubMed         Abstract available
    
    
32. DAVE E, Culhane JF, Lundsberg LS, Partridge C, et al
    Trends in Tdap and influenza vaccination in pregnancy relative to the coronavirus disease-19 pandemic.
    Vaccine. 2025;61:127329.
    PubMed         Abstract available
    
    
33. STOUTEN V, Van Evercooren I, Vernemmen C, Braeye T, et al
    Averted mortality by COVID-19 vaccination in Belgium between 2021 and 2023.
    Vaccine. 2025;60:127290.
    PubMed         Abstract available
    
    
34. NJOH AA, Dinga JN, Kongnyuy EJ, Ndoula TS, et al
    Malaria vaccine acceptance and associated factors in cameroon: A nationwide cross-sectional survey.
    Vaccine. 2025;60:127323.
    PubMed         Abstract available
    
    
35. MARANGOU J, Beaton A, Fulurija A, Carapetis J, et al
    Cardiac monitoring safety assessment framework for early phase group a streptococcal vaccine trials.
    Vaccine. 2025;60:127334.
    PubMed         Abstract available
    
    
36. COBELENS F, Pelzer PT, Churchyard GJ, Garcia-Basteiro A, et al
    Sample size efficiency of restricting participation in tuberculosis vaccine trials to interferon-gamma release assay-positive participants.
    Vaccine. 2025;61:127301.
    PubMed         Abstract available
    
    
37. HARTON PE, Chamberlain AT, Moore A, Fletcher G, et al
    Estimating COVID-19 vaccine effectiveness among children and adolescents using data from a school-based weekly COVID-19 testing program.
    Vaccine. 2025;61:127292.
    PubMed         Abstract available
    
    
38. SAYEM ASM, Musuka G, Atuhebwe PL, Dadari I, et al
    Childhood vaccination catch-up and recovery plans for mitigating immunity gap post the COVID-19 pandemic: A case study of selected African countries.
    Vaccine. 2025;61:127328.
    PubMed         Abstract available
    
    
39. BREWER NT, Rockwell EM, Tomar A, Fisher EB, et al
    Covid-19 vaccine incentives' effectiveness and differential impact on high-risk groups: A prospective cohort study.
    Vaccine. 2025;61:127302.
    PubMed         Abstract available
    
    
40. WAN JIA AARON H, Yuan R, Chan SCS
    Socio-demographic and behavioral predictors of multiple-dose COVID-19 vaccine uptake among older adults in Hong Kong: A community-based cross-sectional study of the generations connect project.
    Vaccine. 2025;61:127308.
    PubMed         Abstract available
    
    
41. JOLFAYI AG, Alipour S, Aminizadeh S, Yaghoubi SM, et al
    Dendritic cell-based vaccines, a promising prospect for ending AIDS and eradication of HIV worldwide: A narrative review on the latest updates.
    Vaccine. 2025;61:127340.
    PubMed         Abstract available
    
    
42. AKTHER A, Laurie C, Elton-Marshall T, Ly V, et al
    Healthcare workers' current practices, knowledge/awareness, barriers, and attitudes/perceptions related to pneumococcal vaccination of older adults: A mixed-methods systematic review.
    Vaccine. 2025;61:127331.
    PubMed         Abstract available
    
    
43. ANASTASSOPOULOU C, Panagiotopoulos AP, Ferous S, Poland GA, et al
    RSV vaccines and Guillain-Barre syndrome: Insights into an emerging concern.
    Vaccine. 2025;61:127338.
    PubMed         Abstract available
    
    
44. HU XX, Qin ZZ, Mo ZY, Wang R, et al
    Timeliness and completeness of serial routine vaccinations among 8062 rural children in southwest China during the COVID-19 pandemic: A multi-stage stratified cluster sampling survey in 1094 villages.
    Vaccine. 2025;61:127346.
    PubMed         Abstract available
    
    
45. HALONEN A, Fan HSL, Masina S, Chooniedass R, et al
    Understanding COVID-19 vaccine hesitancy during parenthood in British Columbia.
    Vaccine. 2025;61:127305.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.